US 10184125
Modulation of TMPRSS6 expression
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10184125 (Modulation of TMPRSS6 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K45/06